-

Dr. Maurice O’Gorman to Speak on AAAS Webinar About Monitoring the Immune System as a Way to Fight COVID-19

original Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

LOS ANGELES--(BUSINESS WIRE)--Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET.

He will be part of an expert panel of speakers that will also include Andrea Cossarizza, MD, PhD, Vice Dean of the School of Medicine at the University of Modena and Reggio Emilia in Italy, and President of the International Society for Advancement of Cytometry, and Lishomwa Ndhlovu, MBBS, PhD, a Professor of immunology at Weill Cornell Medicine in New York and Principal Investigator of the HIV and Emerging Pathogens Immunopathogenesis Laboratory.

Dr. O’Gorman, Chief of Laboratory Medicine at Children's Hospital Los Angeles and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. During this webinar, Dr. O’Gorman will discuss early results from labs around the world that have begun measuring CD4 and CD8 T-cell levels in peripheral blood as potential biomarkers for the prognosis of patients with COVID-19.

Decreased CD4 and CD8 cells means more severe disease.

Hospitals are observing that patients with severe cases of COVID-19 have significantly lower absolute numbers of CD4 and CD8 T-lymphocytes in their peripheral blood, compared to patients with mild or moderate disease. Low numbers of CD4 cells could potentially impact a patient’s ability to form antibodies against the virus, and low CD8 cells could diminish the patient’s ability to eliminate coronavirus from the body.

Dr. O’Gorman will discuss the potential role for routine measurement of CD4 and CD8 T-cells—a process called immunophenotyping—in hospitalized COVID-19 patients participating in clinical trials. Immunophenotyping may provide a tool for prognostics stratification of disease, and potentially as a way to monitor response to treatment.

Register for this Science/AAAS webinar here: https://www.sciencemag.org/custom-publishing/webinars/monitoring-immune-system-fight-covid-19-cd4-status-lymphopenia-and

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

Industry:

Children’s Hospital Los Angeles

Release Summary
CHLA's Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar.
Release Versions
English

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

More News From Children’s Hospital Los Angeles

Children’s Hospital Los Angeles Gala Celebrates Historic $1.35 Billion Anniversary Campaign Milestone

LOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles (CHLA) celebrated a defining milestone in its 125-year history at the 2026 CHLA Gala, announcing the successful completion of its landmark Anniversary Campaign, which raised a record-breaking $1.35 billion to advance pediatric care, research, and education for generations to come. Held at The Event Deck at L.A. Live, the gala brought together philanthropists, community leaders, celebrities, patients, and supporters to celebrate the h...

LA Kings to Match Public Support for Children’s Hospital Los Angeles Annual Halloween Greeting Card Drive, With up to $50,000 Donation

LOS ANGELES--(BUSINESS WIRE)--Excitement is building at Children’s Hospital Los Angeles (CHLA) as it kicks off its beloved Halloween greeting card drive. Supporters from the local community, across the country, and around the world are invited to take part in the hospital’s annual Halloween tradition and spread spooky cheer to patients by going to CHLA.org/Halloween.Participants can choose from three ready-to-color animal designs (a giraffe, a peacock, or an elephant) and write a personal messag...

Desiree Ritter, MHA, BSN, RN, NE-BC, Named Chief Nursing Officer at Children’s Hospital Los Angeles

LOS ANGELES--(BUSINESS WIRE)--Children's Hospital Los Angeles (CHLA) has appointed Desiree Ritter, MHA, BSN, RN, NE-BC, as Senior Vice President of Patient Care Services and Chief Nursing Officer (CNO) after a comprehensive national search. She has been serving in an interim CNO role since July 2026. Ritter will help develop initiatives to enhance and optimize patient care and nursing services; address the developing needs of the community; recruit, retain, and optimize CHLA’s world-class nursi...
Back to Newsroom